An overview of induction and emergence characteristics of desflurane in pediatric, adult, and geriatric patients
- PMID: 1524239
An overview of induction and emergence characteristics of desflurane in pediatric, adult, and geriatric patients
Abstract
A major advantage of desflurane over currently available agents is that the blood-gas partition coefficient of desflurane is 0.42, lower than all available volatile anesthetics, and slightly lower than nitrous oxide. This property predicts rapid induction of and recovery from general anesthesia with desflurane. This review will summarize and compare results of studies that have examined various clinical characteristics of induction and emergence with desflurane in a variety of patient populations. Studies in pediatric patients, and in adults, have confirmed that inhalation induction with desflurane is rapid. However, there has been a high incidence of airway irritation and/or reactivity, including breath holding, coughing, excessive secretions, and laryngospasm. This incidence is significantly higher than that seen with halothane, making it unlikely that desflurane will supplant halothane for inhalation inductions. The hemodynamic effects of desflurane induction and maintenance with or without intravenous adjuvants appear similar to those seen with isoflurane. Several studies have compared emergence from anesthesia with desflurane with that from isoflurane-based anesthetics, and have demonstrated that initial emergence from a given depth of anesthesia, e.g., time to eye opening or response to verbal commands, is about twice as fast with desflurane. Similar results have been obtained in pediatric patients where emergence from desflurane is faster than that seen from halothane. Emergence from desflurane anesthesia appears similar in time-course to that from propofol-based anesthetics.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Desflurane versus sevoflurane for maintenance of outpatient anesthesia: the effect on early versus late recovery and perioperative coughing.Anesth Analg. 2009 Aug;109(2):387-93. doi: 10.1213/ane.0b013e3181adc21a. Anesth Analg. 2009. PMID: 19608808 Clinical Trial.
-
Studies of desflurane in outpatient anesthesia.Anesth Analg. 1992 Oct;75(4 Suppl):S47-53; discussion S53-4. Anesth Analg. 1992. PMID: 1524240 Review.
-
Airway responses to desflurane during maintenance of anesthesia and recovery in children with laryngeal mask airways.Paediatr Anaesth. 2010 Jun;20(6):495-505. doi: 10.1111/j.1460-9592.2010.03305.x. Epub 2010 Apr 23. Paediatr Anaesth. 2010. PMID: 20456065 Clinical Trial.
-
Use of desflurane for outpatient anesthesia. A comparison with propofol and nitrous oxide.Anesthesiology. 1991 Aug;75(2):197-203. doi: 10.1097/00000542-199108000-00005. Anesthesiology. 1991. PMID: 1830462 Clinical Trial.
-
Desflurane animal and human pharmacology: aspects of kinetics, safety, and MAC.Anesth Analg. 1992 Oct;75(4 Suppl):S3-7; discussion S8-9. Anesth Analg. 1992. PMID: 1524237 Review.
Cited by
-
Desflurane reinforces the efficacy of propofol target-controlled infusion in patients undergoing laparoscopic cholecystectomy.Kaohsiung J Med Sci. 2016 Jan;32(1):32-7. doi: 10.1016/j.kjms.2015.11.006. Epub 2016 Jan 12. Kaohsiung J Med Sci. 2016. PMID: 26853173 Free PMC article. Clinical Trial.
-
Desflurane clinical pharmacokinetics and pharmacodynamics.Clin Pharmacokinet. 1994 Jul;27(1):6-18. doi: 10.2165/00003088-199427010-00002. Clin Pharmacokinet. 1994. PMID: 7955772 Review.
-
Influence of intraoperative sevoflurane or desflurane on postoperative sore throat: a prospective randomized study.J Anesth. 2019 Apr;33(2):209-215. doi: 10.1007/s00540-018-2600-y. Epub 2019 Jan 2. J Anesth. 2019. PMID: 30603828 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources